Researchers at the Max Planck Institute for Terrestrial Microbiology have discovered the biosynthesis of a rare compound called benzoxazolinate, which is found in Benzobactins – a class of bacterial natural products that have unique biological activity due to its two-ring structure.
By utilizing genomic research, scientists were able to uncover the previously unknown genes responsible for its formation. This breakthrough opens doors to the discovery of a multitude of new natural compounds with medical applications.
Microorganisms in their natural habitat often face varying environmental conditions and have evolved to produce a diverse range of natural products with various chemical compositions and functions to aid their survival.
Comments are closed.